Lipid A, the hydrophobic anchor of lipopolysaccharide (LPS), is an essential component in the outer membrane of Gram-negative bacteria. It can stimulate the innate immune system via Toll-like receptor 4/myeloid differentiation factor 2 (TLR4/MD2), leading to the release of inflammatory cytokines. In this study, six Escherichia coli strains which can produce lipid A with different acylation patterns were constructed; the influence of lipid A acylation pattern on the membrane permeability and innate immune stimulation has been systematically investigated. The lipid A species were isolated and identified by matrix assisted laser ionization desorption-time of flight/tandem mass spectrometry. N-Phenyl naphthylamine uptake assay and antibiotic susceptibility test showed that membrane permeability of these strains were different. The lower the number of acyl chains in lipid A, the stronger the membrane permeability. LPS purified from these strains were used to stimulate human or mouse macrophage cells, and different levels of cytokines were induced. Compared with wild type hexa-acylated LPS, penta-acylated, tetra-acylated and tri-acylated LPS induced lower levels of cytokines. These results suggest that the lipid A acylation pattern influences both the bacterial membrane permeability and innate immune stimulation. The results would be useful for redesigning the bacterial membrane structure and for developing lipid A vaccine adjuvant.
Raetz, C.R.; Reynolds, C.M.; Trent, M.S.; Bishop, R.E. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 2007, 76, 295–329, doi:10.1146/annurev.biochem.76.010307.145803.
[5]
Raetz, C.R.; Garrett, T.A.; Reynolds, C.M.; Shaw, W.A.; Moore, J.D.; Smith, D.C., Jr.; Ribeiro, A.A.; Murphy, R.C.; Ulevitch, R.J.; Fearns, C.; et al. Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J. Lipid Res. 2006, 47, 1097–1111, doi:10.1194/jlr.M600027-JLR200.
[6]
Wang, X.; Ribeiro, A.A.; Guan, Z.; Raetz, C.R. Identification of undecaprenyl phosphate-beta-d-galactosamine in Francisella novicida and its function in lipid A modification. Biochemistry 2009, 48, 1162–1172, doi:10.1021/bi802211k.
[7]
Li, Y.; Powell, D.A.; Shaffer, S.A.; Rasko, D.A.; Pelletier, M.R.; Leszyk, J.D.; Scott, A.J.; Masoudi, A.; Goodlett, D.R.; Wang, X.; et al. LPS remodeling is an evolved survival strategy for bacteria. Proc. Natl. Acad. Sci. USA 2012, 109, 8716–8721, doi:10.1073/pnas.1202908109.
[8]
Rebeil, R.; Ernst, R.K.; Jarrett, C.O.; Adams, K.N.; Miller, S.I.; Hinnebusch, B.J. Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J. Bacteriol. 2006, 188, 1381–1388, doi:10.1128/JB.188.4.1381-1388.2006.
Guo, L.; Lim, K.B.; Gunn, J.S.; Bainbridge, B.; Darveau, R.P.; Hackett, M.; Miller, S.I. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276, 250–253, doi:10.1126/science.276.5310.250.
[11]
Groisman, E.A. The pleiotropic two-component regulatory system PhoP-PhoQ. J. Bacteriol. 2001, 183, 1835–1842, doi:10.1128/JB.183.6.1835-1842.2001.
[12]
Gunn, J.S.; Ryan, S.S.; van Velkinburgh, J.C.; Ernst, R.K.; Miller, S.I. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect. Immun. 2000, 68, 6139–6146, doi:10.1128/IAI.68.11.6139-6146.2000.
[13]
Trent, M.S.; Pabich, W.; Raetz, C.R.; Miller, S.I. A PhoP/PhoQ-induced lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J. Biol. Chem. 2001, 276, 9083–9092, doi:10.1074/jbc.M010730200.
[14]
Kawasaki, K.; Ernst, R.K.; Miller, S.I. 3-O-Deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J. Biol. Chem. 2004, 279, 20044–20048, doi:10.1074/jbc.M401275200.
[15]
Casella, C.R.; Mitchell, T.C. Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol. Life Sci. 2008, 65, 3231–3240, doi:10.1007/s00018-008-8228-6.
[16]
Needham, B.D.; Carroll, S.M.; Giles, D.K.; Georgiou, G.; Whiteley, M.; Trent, M.S. Modulating the innate immune response by combinatorial engineering of endotoxin. Proc. Natl. Acad. Sci. USA 2013, 110, 1464–1469, doi:10.1073/pnas.1218080110.
[17]
Mata-Haro, V.; Cekic, C.; Martin, M.; Chilton, P.M.; Casella, C.R.; Mitchell, T.C. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007, 316, 1628–1632, doi:10.1126/science.1138963.
Karow, M.; Georgopoulos, C. Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. J. Bacteriol. 1992, 174, 702–710.
[20]
Vorachek-Warren, M.K.; Ramirez, S.; Cotter, R.J.; Raetz, C.R. A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A. J. Biol. Chem. 2002, 277, 14194–14205, doi:10.1074/jbc.M200409200.
[21]
Vuorio, R.; Vaara, M. Comparison of the phenotypes of the lpxA and lpxD mutants of Escherichia coli.. FEMS Microbiol. Lett. 1995, 134, 227–232, doi:10.1111/j.1574-6968.1995.tb07942.x.
[22]
Vaara, M.; Nurminen, M. Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis. Antimicrob. Agents Chemother. 1999, 43, 1459–1462.
[23]
Park, B.S.; Song, D.H.; Kim, H.M.; Choi, B.S.; Lee, H.; Lee, J.O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458, 1191–1195, doi:10.1038/nature07830.
[24]
Folch, J.; Lees, M.; Sloane-Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509.
[25]
Hirschfeld, M.; Ma, Y.; Weis, J.H.; Vogel, S.N.; Weis, J.J. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 2000, 165, 618–622.
[26]
Caroff, M.; Tacken, A.; Szabo, L. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the “isolated lipid A” fragment of the Bordetella pertussis endotoxin. Carbohydr. Res. 1988, 175, 273–282, doi:10.1016/0008-6215(88)84149-1.
[27]
Li, Y.; Wang, X.; Ernst, R.K. A rapid one-step method for the characterization of membrane lipid remodeling in Francisella using matrix-assisted laser desorption ionization time-of-flight tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25, 2641–2648.
[28]
Helander, I.M.; Mattila-Sandholm, T. Fluorometric assessment of gram-negative bacterial permeabilization. J. Appl. Microbiol. 2000, 88, 213–219, doi:10.1046/j.1365-2672.2000.00971.x.
[29]
Ernst, R.K.; Guina, T.; Miller, S.I. How intracellular bacteria survive: Surface modifications that promote resistance to host innate immune responses. J. Infect. Dis. 1999, 179, S326–S330.
[30]
Wang, R.F.; Kushner, S.R. Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli.. Gene 1991, 100, 195–199, doi:10.1016/0378-1119(91)90366-J.
[31]
Westphal, O.; Jann, K. Bacterial lipopolysaccharides: Extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 1965, 5, 83–91.
[32]
Six, D.; Carty, S.M.; Guan, Z.; Raetz, C.R. Purification and mutagenesis of LpxL, the lauroyltransferase of Escherichia coli lipid A biosynthesis. Biochemistry 2008, 47, 8623–8637, doi:10.1021/bi800873n.
